Health

Trastuzumab Deruxtecan Scores Two Wins in HER2-Positive Early Breast Cancer

TribeNews
By TribeNews 1 View Add a Comment
0 Min Read
Trastuzumab Deruxtecan Scores Two Wins in HER2-Positive Early Breast Cancer

MedPage Today) — BERLIN — The antibody-drug conjugate (ADC) trastuzumab deruxtecan (T-DXd, Enhertu) delivered impressive results in different HER2-positive early-stage breast cancer settings in back-to-back randomized clinical trials.
In…

Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app